MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,490K
EPS
-$0.24
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2024-12-31
2024-09-30
Research and development
-
12,922*
14,424
General and administrative
-
4,558*
3,944
Total operating expenses
-
17,480
18,368
Loss from operations
-
-17,480*
-18,368
Other income, net
-
134*
520
Net loss before income taxes
-
-17,346*
-17,848
Other segment expense
218
-
-
Research and development-TIDAL-01
-48
-
-
Research and development-Compensation
406
-
-
Other income, net
81
-
-
Provision for income taxes
12
-
-
General and administrative
5,388
-
-
Benefit (provision) for income taxes
-
2,485*
-816
Depreciation expense
31
-
-
Net loss
-5,490
-19,831
-17,032
Oci, debt securities, available-for-sale, gain (loss), before adjustment, after tax, total
-
-
30
Net loss attributable to common stockholders, basic
-
-19,831
-
Comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest
-
-
-17,002
Net loss attributable to common stockholders, diluted
-
-19,831
-
Basic EPS
-0.24
-0.861
-0.74
Diluted EPS
-0.24
-0.861
-0.74
Basic Average Shares
23,140,510
23,036,442
23,037,714
Diluted Average Shares
23,140,510
23,036,442
23,037,714
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$5,490K
Other segment expense
$218K
Other income, net
$81K
Research and
development-TIDAL-01
-$48K
General and
administrative
$5,388K
Research and
development-Compensation
$406K
Depreciation expense
$31K
Provision for income taxes
$12K
Buy us a coffee
Turnstone Biologics Corp. (TSBX)
Turnstone Biologics Corp. (TSBX)